175 related articles for article (PubMed ID: 23288280)
1. Herpes zoster knowledge, prevalence, and vaccination rate by race.
Joon Lee T; Hayes S; Cummings DM; Cao Q; Carpenter K; Heim L; Edwards H
J Am Board Fam Med; 2013; 26(1):45-51. PubMed ID: 23288280
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Physician Attitudes and Practices Regarding Herpes Zoster Vaccination.
Tsui E; Gillespie C; Perskin M; Zabar S; Wu M; Cohen EJ
Cornea; 2018 Aug; 37(8):947-951. PubMed ID: 29578865
[TBL] [Abstract][Full Text] [Related]
4. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
Lu PJ; Euler GL; Jumaan AO; Harpaz R
Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study.
Valente N; Lupi S; Stefanati A; Cova M; Sulcaj N; Piccinni L; ; Gabutti G
BMJ Open; 2016 Oct; 6(10):e011539. PubMed ID: 27797989
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster vaccine awareness among people ≥ 50 years of age and its implications on immunization.
Javed S; Javed F; Mays RM; Tyring SK
Dermatol Online J; 2012 Aug; 18(8):2. PubMed ID: 22948052
[TBL] [Abstract][Full Text] [Related]
8. Knowledge, attitudes, and practices of the general population, herpes zoster patients, and dermatologists toward herpes zoster in China: A quantitative cross-sectional survey.
Chang C; Tang H; Zhang X; Zhu C; Feng Y; Ye C
Hum Vaccin Immunother; 2024 Dec; 20(1):2338980. PubMed ID: 38898574
[TBL] [Abstract][Full Text] [Related]
9. Preferences for herpes zoster vaccination among adults aged 50 years and older in the United States: results from a discrete choice experiment.
Patterson BJ; Myers K; Stewart A; Mange B; Hillson EM; Poulos C
Expert Rev Vaccines; 2021 Jun; 20(6):729-741. PubMed ID: 33902368
[TBL] [Abstract][Full Text] [Related]
10. Studying physician knowledge, attitudes, and practices regarding the herpes zoster vaccine to address perceived barriers to vaccination.
Elkin Z; Cohen EJ; Goldberg JD; Gillespie C; Li X; Jung J; Cohen M; Park L; Perskin MH
Cornea; 2013 Jul; 32(7):976-81. PubMed ID: 23449488
[TBL] [Abstract][Full Text] [Related]
11. Shingles vaccination uptake in Massachusetts adults aged 50 years and older.
Draper M; Stergiopoulos S
Vaccine; 2021 Nov; 39(46):6781-6786. PubMed ID: 34625290
[TBL] [Abstract][Full Text] [Related]
12. Improving adherence to national recommendations for zoster vaccination through simple interventions.
Elkin ZP; Cohen EJ; Goldberg JD; Li X; Castano E; Gillespie C; Haberman I; Jung JJ; Zabar S; Park L; Perskin MH
Eye Contact Lens; 2014 Jul; 40(4):225-31. PubMed ID: 24901974
[TBL] [Abstract][Full Text] [Related]
13. Knowledge, attitude, and practice toward herpes zoster (HZ) and HZ vaccination: Concept elicitation findings from a multi-country study in the Asia Pacific.
Chen J; Shantakumar S; Si J; Gowindah R; Parikh R; Chan F; Chan M; Choi WS; Huang E; Huang KC; Huang LM; Kim H; Leong CK; Leong HN; Seo Y; Williams C; Wong AT
Hum Vaccin Immunother; 2024 Dec; 20(1):2317446. PubMed ID: 38436584
[TBL] [Abstract][Full Text] [Related]
14. National and State-Specific Shingles Vaccination Among Adults Aged ≥60 Years.
Lu PJ; O'Halloran A; Williams WW; Harpaz R
Am J Prev Med; 2017 Mar; 52(3):362-372. PubMed ID: 27720342
[TBL] [Abstract][Full Text] [Related]
15. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.
Aziz M; Kessler H; Huhn G
Int J STD AIDS; 2013 Jun; 24(6):433-9. PubMed ID: 23970744
[TBL] [Abstract][Full Text] [Related]
16. Awareness, Knowledge, and Vaccine Acceptability of Herpes Zoster in Korea: A Multicenter Survey of 607 Patients.
Roh NK; Park YM; Kang H; Choi GS; Kim BJ; Lee YW; Lew BL; Sim WY
Ann Dermatol; 2015 Oct; 27(5):531-8. PubMed ID: 26512167
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
Marin M; Yawn BP; Hales CM; Wollan PC; Bialek SR; Zhang J; Kurland MJ; Harpaz R
Hum Vaccin Immunother; 2015; 11(5):1157-64. PubMed ID: 25806911
[TBL] [Abstract][Full Text] [Related]
18. An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals.
Klaric JS; Beltran TA; McClenathan BM
Mil Med; 2019 Mar; 184(Suppl 1):126-132. PubMed ID: 30901393
[TBL] [Abstract][Full Text] [Related]
19. Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project.
Sheth H; Moreland L; Peterson H; Aggarwal R
J Rheumatol; 2017 Jan; 44(1):11-17. PubMed ID: 28042124
[TBL] [Abstract][Full Text] [Related]
20. The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
Zhang J; Delzell E; Xie F; Baddley JW; Spettell C; McMahan RM; Fernandes J; Chen L; Winthrop K; Curtis JR
Arthritis Res Ther; 2011; 13(5):R174. PubMed ID: 22024532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
